Standard BioTools
LAB
LAB
86 hedge funds and large institutions have $116M invested in Standard BioTools in 2023 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
5.56% more ownership
Funds ownership: 60.06% → 65.62% (+5.6%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
16% less capital invested
Capital invested by funds: $138M → $116M (-$21.4M)
Holders
86
Holding in Top 10
2
Calls
$30K
Puts
$1K
Top Buyers
| 1 | +$7.52M | |
| 2 | +$2.32M | |
| 3 | +$942K | |
| 4 |
LCM
Laurion Capital Management
New York
|
+$663K |
| 5 |
Jane Street
New York
|
+$619K |
Top Sellers
| 1 | -$1.37M | |
| 2 | -$1.28M | |
| 3 | -$1.14M | |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$880K |
| 5 |
D.E. Shaw & Co
New York
|
-$419K |